DS
Da Silva Jorge Santos sold $957K of MLTX stock
Da Silva Jorge Santos, Chief Executive Officer of MoonLake Immunotherapeutics (MLTX), sold 47,775 shares of MLTX stock worth $957K, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 1, 2026, 1 day before it was made public.
MLTX has moved -34.3% since the trade date, from $19.13 to $12.56 (Nov 10, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 1 day
- Price since
- -34.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4